Loading calculators...
Fetching calculator categories and tools for this section.
Preparing tools and content for you. This usually takes a second.
Fetching calculator categories and tools for this section.
Compute total cholesterol to HDL (TC/HDL), optional LDL to HDL, and non-HDL cholesterol from your lipid panel in mg/dL or mmol/L. Teaching bands summarize epidemiologic risk patterns—pair with ASCVD risk tools and clinician-set LDL/non-HDL goals, not ratios alone.
Last updated: June 4, 2026
TC / HDL
4
Desirable
Non-HDL (mg/dL)
150
Borderline high
TC/HDL interpretation
Ratios in this range are generally considered favorable. Your clinician may still set targets based on your overall risk, age, and conditions such as diabetes or prior cardiovascular disease.
Non-HDL: Non-HDL 130–159 mg/dL may prompt lifestyle optimization and ASCVD risk discussion. Targets tighten with diabetes, prior ASCVD, or very high LDL.
LDL / HDL
2.4
Near optimal
Ratios between 2 and 3 are common; your clinician may interpret this in context of your other numbers and risk factors.
This tool is for education only. Lipid targets depend on age, sex, blood pressure, diabetes, smoking, family history, and prior cardiovascular disease. Do not start, stop, or change medications based on a website calculator.
Typical panel (demo)
TC/HDL 4
Non-HDL 150 mg/dL · Desirable
Favorable profile
TC/HDL 3
TC 180, HDL 60 mg/dL
Higher-risk pattern
TC/HDL 6
Non-HDL 200 mg/dL · LDL/HDL 3.8
SI units (mmol/L)
TC/HDL 4
5.2 / 1.3 mmol/L → same ratio math
| TC/HDL | Category | Teaching note |
|---|---|---|
| < 3.5 | Very favorable | Often lowest average risk in epidemiologic cohorts |
| 3.5 – 4.4 | Desirable | Generally favorable; still personalize with ASCVD risk |
| 4.5 – 4.9 | Borderline | Lifestyle review and repeat lipids reasonable |
| 5.0 – 5.9 | High | Higher population risk; clinician may intensify prevention |
| ≥ 6.0 | Very high | Warrants medical follow-up; not a diagnosis alone |
| LDL/HDL | Category | Teaching note |
|---|---|---|
| < 2.0 | Optimal | Lower atherogenic burden relative to HDL |
| 2.0 – 2.9 | Near optimal | Common in general populations |
| 3.0 – 3.9 | Borderline high | Discuss LDL and non-HDL goals |
| ≥ 4.0 | High | More atherogenic pattern on average |
| Non-HDL | Category | Teaching note |
|---|---|---|
| < 130 | Desirable (many adults) | Often aligned with moderate-risk non-HDL goals in US frameworks |
| 130 – 159 | Borderline high | Lifestyle and risk-based statin discussion common |
| 160 – 189 | High | May meet criteria for therapy when risk is elevated |
| ≥ 190 | Very high | Screen for familial hypercholesterolemia patterns; urgent review if symptomatic |
| Measure | Formula / source | Strength | Limitation |
|---|---|---|---|
| TC/HDL ratio | Total cholesterol ÷ HDL | Simple panel summary; widely used in research | Does not replace LDL targets or formal ASCVD risk scores |
| LDL/HDL ratio | LDL ÷ HDL (when LDL reported) | Highlights atherogenic vs protective cholesterol balance | Friedewald LDL inaccurate when triglycerides are very high |
| Non-HDL cholesterol | Total − HDL (mg/dL) | Captures LDL + VLDL; emphasized when TG elevated | Goals vary by risk tier (diabetes, prior ASCVD, FH) |
| LDL-C (absolute) | Direct or calculated LDL | Primary statin intensity driver in US/EU guidelines | Single number without blood pressure, smoking, diabetes context |
| 10-year ASCVD risk (PCE) | Age, sex, TC, HDL, BP, smoking, diabetes, Rx | Guides statin initiation in primary prevention (US) | Underestimates risk in some ethnicities and inflammatory conditions |
TC/HDL = Total cholesterol ÷ HDLLDL/HDL = LDL ÷ HDL (optional)Non-HDL (mg/dL) = Total (mg/dL) − HDL (mg/dL)mmol/L → mg/dL: multiply cholesterol by 38.67Lipid management today centers on LDL cholesterol, non-HDL or apoB when triglycerides are high, blood pressure, smoking, diabetes, and inflammatory risk—not ratios in isolation. HDL-raising drugs beyond lifestyle have not consistently reduced events; lowering LDL with statins and adjuncts has the strongest evidence base for ASCVD prevention.
TC/HDL = 200 ÷ 50 = 4 (Desirable)
Non-HDL = 200 − 50 = 150 mg/dL (Borderline high)
LDL/HDL = 120 ÷ 50 = 2.4 (Near optimal)
Ratios in this range are generally considered favorable. Your clinician may still set targets based on your overall risk, age, and conditions such as diabetes or prior cardiovascular disease.
TC/HDL = 240 ÷ 40 = 6 (Very high)
Non-HDL = 200 mg/dL — often above moderate-risk non-HDL goals
LDL/HDL = 150 ÷ 40 = 3.8 (Borderline high)
A clinician would integrate smoking, blood pressure, diabetes, family history, and prior ASCVD—not treat based on ratio alone.
Education only. Not for diagnosing hyperlipidemia, starting statins, or emergency chest pain. Lipid targets depend on age, sex, ASCVD risk, diabetes, and prior cardiovascular disease.
For lipid education and cardiometabolic teaching
Suggested hashtags: #Cholesterol #HeartHealth #Lipids #MedEd